Betta Pharmaceuticals Co., Ltd. (SHE: 300558)
China
· Delayed Price · Currency is CNY
47.39
-1.12 (-2.31%)
Nov 15, 2024, 3:04 PM CST
Betta Pharmaceuticals Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 595.34 | 752 | 731.28 | 791.99 | 1,346 | 521.3 | Upgrade
|
Short-Term Investments | - | - | - | - | 190 | - | Upgrade
|
Trading Asset Securities | 221.04 | 0.54 | - | 201.01 | - | - | Upgrade
|
Cash & Short-Term Investments | 816.38 | 752.54 | 731.28 | 993 | 1,536 | 521.3 | Upgrade
|
Cash Growth | 17.58% | 2.91% | -26.36% | -35.35% | 194.64% | 70.93% | Upgrade
|
Accounts Receivable | 228.3 | 286.41 | 450.62 | 173.38 | 52.61 | 56.03 | Upgrade
|
Other Receivables | 1.77 | 2.61 | 49.7 | 40.75 | 6.81 | 1.64 | Upgrade
|
Receivables | 230.07 | 289.02 | 500.32 | 214.13 | 59.42 | 57.67 | Upgrade
|
Inventory | 289.09 | 327.5 | 372.17 | 293.32 | 188.59 | 134.57 | Upgrade
|
Prepaid Expenses | - | 0.2 | - | - | - | - | Upgrade
|
Other Current Assets | 191.03 | 156.62 | 129.06 | 153.49 | 63.91 | 78.7 | Upgrade
|
Total Current Assets | 1,527 | 1,526 | 1,733 | 1,654 | 1,848 | 792.24 | Upgrade
|
Property, Plant & Equipment | 2,837 | 2,574 | 2,056 | 1,331 | 775.72 | 789.92 | Upgrade
|
Long-Term Investments | 1,356 | 1,382 | 919.27 | 345.79 | 274.55 | 118.72 | Upgrade
|
Goodwill | 413.58 | 413.58 | 413.58 | 413.58 | 413.58 | 427.45 | Upgrade
|
Other Intangible Assets | 1,783 | 1,944 | 1,219 | 1,183 | 603.37 | 486.19 | Upgrade
|
Long-Term Deferred Tax Assets | 38.94 | 39.13 | 85.96 | 55.06 | 55.22 | 29.49 | Upgrade
|
Long-Term Deferred Charges | 1,371 | 1,219 | 1,444 | 1,252 | 1,171 | 913.07 | Upgrade
|
Other Long-Term Assets | 32.64 | 50.3 | 39.3 | 37.6 | 87.79 | 576.24 | Upgrade
|
Total Assets | 9,358 | 9,147 | 7,910 | 6,271 | 5,230 | 4,133 | Upgrade
|
Accounts Payable | 712.53 | 10.67 | 35.85 | 431.19 | 113.62 | 29.25 | Upgrade
|
Accrued Expenses | 133.38 | 268.86 | 419.11 | 357.02 | 187.53 | 164.56 | Upgrade
|
Short-Term Debt | 111.08 | 300.27 | 380.39 | - | - | 363.23 | Upgrade
|
Current Portion of Long-Term Debt | 565.96 | 301.25 | - | - | - | - | Upgrade
|
Current Portion of Leases | - | 4.6 | 4.16 | 4.88 | - | - | Upgrade
|
Current Income Taxes Payable | 16.37 | 0.07 | 0.04 | 10.68 | 27.54 | 11.03 | Upgrade
|
Current Unearned Revenue | 1.75 | 4.92 | 4.46 | 0.69 | 1.27 | 48.73 | Upgrade
|
Other Current Liabilities | 235.83 | 912.51 | 1,261 | 84.4 | 108.14 | 88.39 | Upgrade
|
Total Current Liabilities | 1,777 | 1,803 | 2,105 | 888.86 | 438.1 | 705.2 | Upgrade
|
Long-Term Debt | 1,645 | 1,816 | 656.03 | - | 2.6 | 280 | Upgrade
|
Long-Term Leases | 6.14 | 8.18 | 7.3 | 6.34 | - | - | Upgrade
|
Long-Term Unearned Revenue | 154.31 | 144.7 | 112.76 | 112 | 58.01 | 57.77 | Upgrade
|
Long-Term Deferred Tax Liabilities | 49.03 | 23.39 | 71.57 | 68.39 | 64.64 | 63.05 | Upgrade
|
Other Long-Term Liabilities | - | - | - | 510.06 | 521.99 | 558.1 | Upgrade
|
Total Liabilities | 3,632 | 3,795 | 2,952 | 1,586 | 1,085 | 1,664 | Upgrade
|
Common Stock | 418.49 | 418.49 | 417.47 | 415.39 | 413.16 | 401 | Upgrade
|
Additional Paid-In Capital | 2,215 | 1,945 | 1,860 | 1,932 | 1,793 | 654.87 | Upgrade
|
Retained Earnings | 2,848 | 2,503 | 2,181 | 2,139 | 1,883 | 1,353 | Upgrade
|
Comprehensive Income & Other | 156.15 | 384.48 | 390.99 | 74.64 | 52.28 | 51.94 | Upgrade
|
Total Common Equity | 5,637 | 5,251 | 4,849 | 4,561 | 4,141 | 2,461 | Upgrade
|
Minority Interest | 89.16 | 100.4 | 108.64 | 124.9 | 3.41 | 8.68 | Upgrade
|
Shareholders' Equity | 5,726 | 5,351 | 4,958 | 4,686 | 4,144 | 2,469 | Upgrade
|
Total Liabilities & Equity | 9,358 | 9,147 | 7,910 | 6,271 | 5,230 | 4,133 | Upgrade
|
Total Debt | 2,329 | 2,430 | 1,048 | 11.22 | 2.6 | 643.23 | Upgrade
|
Net Cash (Debt) | -1,512 | -1,678 | -316.59 | 981.77 | 1,533 | -121.94 | Upgrade
|
Net Cash Growth | - | - | - | -35.97% | - | - | Upgrade
|
Net Cash Per Share | -3.57 | -3.99 | -0.76 | 2.36 | 3.77 | -0.30 | Upgrade
|
Filing Date Shares Outstanding | 418.49 | 418.49 | 417.47 | 415.39 | 413.16 | 401 | Upgrade
|
Total Common Shares Outstanding | 418.49 | 418.49 | 417.47 | 415.39 | 413.16 | 401 | Upgrade
|
Working Capital | -250.33 | -277.28 | -371.95 | 765.08 | 1,410 | 87.04 | Upgrade
|
Book Value Per Share | 13.47 | 12.55 | 11.62 | 10.98 | 10.02 | 6.14 | Upgrade
|
Tangible Book Value | 3,441 | 2,894 | 3,216 | 2,964 | 3,124 | 1,547 | Upgrade
|
Tangible Book Value Per Share | 8.22 | 6.92 | 7.70 | 7.14 | 7.56 | 3.86 | Upgrade
|
Buildings | - | 586.14 | 585.59 | 627.19 | 588.32 | 591.46 | Upgrade
|
Machinery | - | 424.26 | 402.25 | 376.01 | 339.24 | 240.06 | Upgrade
|
Construction In Progress | - | 2,037 | 1,448 | 639.67 | 63.12 | 112.31 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.